Switching from one CD20-targeting therapy to another doesn't alter their ability to lower disease activity and slow ...

This budget law is nothing but cruel. They threw billions at tax breaks for the wealthy without blinking, but keeping Arizonans with disabilities alive is too expensive.

As drug companies increasingly adopt the DTC sales model, patients will gain the ability to buy the medicines they need at ...

Halozyme Therapeutics reports a record Q2 2025, with 41% revenue growth. Discover raised guidance, strong catalysts, and shareholder-focused initiatives.

Combining preconception, gestation, and postpartum periods, the total effect of pregnancy raised relapse rates (cRR 1.07, 95% ...

BIIB posts Q2 earnings and sales beat, lifts 2025 outlook on new drug growth and displays resilient MS performance.

In the preceding three months, 8 analysts have released ratings for Biogen BIIB -0.98% Get Free Report , presenting a wide ...

Women in their childbearing years are significantly less likely than men in the same age range to be given disease-modifying ...

VANCOUVER, BC, Aug. 7, 2025 /CNW/ - Teresa Alfeld, a filmmaker who was recently diagnosed with multiple sclerosis (MS), is calling for the provincial ...

MS Ocrevus generated sales of $3.5 billion, up 8%. Sales of hemophilia A drug Hemlibra surged 17% year over year to CHF 2.4 billion.

Following NICE's rejection of Ocrevus in PPMS, more than 21,000 patients had signed a petition calling for a rethink, and more than 3,000 people raised the issue with their local MP, the MS ...